Morgan Stanley Merrimack Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Oct 17, 2024	BUY	$13.06 - $15.0 $515,112 - $591,630	39,442 New	39,442 $582,000
Q1 2024 Aug 16, 2024	SELL	$13.06 - $15.0 $915,453 - $1.05 Million	-70,096 Reduced 63.99%	39,442 $582,000
Q1 2024 May 15, 2024	SELL	$13.06 - $15.0 $915,453 - $1.05 Million	-70,096 Reduced 63.99%	39,442 $582,000
Q4 2023 Aug 16, 2024	BUY	$12.02 - $13.41 $1.32 Million - $1.47 Million	109,538 New	109,538 $1.47 Million
Q4 2023 Feb 13, 2024	BUY	$12.02 - $13.41 $196,659 - $219,401	16,361 Added 17.56%	109,538 $1.47 Million
Q3 2023 Nov 15, 2023	BUY	$11.6 - $12.52 $121,707 - $131,359	10,492 Added 12.69%	93,177 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$12.02 - $13.07 $342,870 - $372,821	28,525 Added 52.67%	82,685 $1.02 Million
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $510,715 - $554,363	44,997 Added 491.07%	54,160 $665,000
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $9,748 - $33,138	2,649 Added 40.67%	9,163 $105,000
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $3,122 - $5,114	-844 Reduced 11.47%	6,514 $25,000
Q2 2022 Oct 27, 2022	BUY	$4.89 - $7.13 $6,039 - $8,805	1,235 Added 20.17%	7,358 $43,000
Q2 2022 Aug 15, 2022	BUY	$4.89 - $7.13 $6,039 - $8,805	1,235 Added 20.17%	7,358 $43,000
Q1 2022 Oct 27, 2022	SELL	$3.75 - $6.82 $4,631 - $8,422	-1,235 Reduced 16.78%	6,123 $39,000
Q1 2022 May 13, 2022	BUY	$3.75 - $6.82 $3,753 - $6,826	1,001 Added 19.54%	6,123 $39,000
Q4 2021 Feb 14, 2022	SELL	$3.75 - $5.1 $2,647 - $3,600	-706 Reduced 12.11%	5,122 $19,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $6.39 $25,060 - $37,240	5,828 New	5,828 $28,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.